MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about COMPASS Pathways

Recent news which mentions COMPASS Pathways

COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
Tickers CMPS NEWS
Tags Psychedelics Cannabis market cap
From Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Tickers CMPS NEWS
Tags COMP006 Psychedelics Cannabis
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Tickers CMPS NEWS
Tags Compass Pathways COMP360 Xi Zhu
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Tickers ATAI CMPS DMT MBIO
Tags Compass Pathways Psychedelic Assisted Therapies DMT
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Tickers ABBV ATAI CMPS COMP
Tags Johnson & Johnson ATAI News
From Benzinga
AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
Tickers CMPS NEWS
Tags Psychedelic Therapy Reimbursement Markets Psychedelics
From Benzinga
The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways (NASDAQ: CMPS) Is Advancing It
Tickers CMPS
Tags COMPASS Pathways XNAS:CMPS
From TheNewswire.com - RSS (Media)
The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways (NASDAQ: CMPS) Is Advancing It
Tickers CMPS
Tags Partner Content Psilocybin Market News
From Benzinga
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care
Tickers BRTX CMPS
Tags COMPASS Pathways XNAS:CMPS
From TheNewswire.com - RSS (Media)
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space
Tickers CMPS
Tags COMPASS Pathways XNAS:CMPS
From TheNewswire.com - RSS (Media)
One Year Into Kabir Nath’s Leadership, Compass Pathways’ (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
Tickers BMS CMPS GSK
Tags COMPASS Pathways XNAS:CMPS
From TheNewswire.com - RSS (Media)
One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
Tickers BMS CMPS GSK
Tags Partner Content Market News CMPS
From Benzinga
What's Spurring The Growth Of The Psychedelics Market – And How One Company Is Helping As Part Of The Vanguard In This Emerging Field
Tickers CMPS
Tags Biotech Small Cap Psychedelic
From Benzinga
AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies
Tickers CMPS
Tags COMPASS Pathways XNAS:CMPS
From TheNewswire.com - RSS (Media)
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
Tickers CMPS
Tags Compass Pathways MAPS PBC Market News
From Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Tickers CMPS IWINF IXHL NUMIF
Tags Compass Pathways Market News F/I/V/E/
From Benzinga
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
Tickers CMPS
Tags Management Guidance FDA
From Benzinga
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know
Tickers BMY CMPS DMTTF GS
Tags George Tziras George Goldsmith Management
From Benzinga
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say
Tickers CMPS FLHLF
Tags United States Patent and Trademark Office Penny Stocks General
From Benzinga
Compass Pathways Partners With One Mind To Fund Rising Star Awards
Tickers CMPS
Tags Benzinga Compass Pathways CMPS
From Benzinga
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
Tickers ATAI CMPS IGXT
Tags CMPS Small Cap Benzinga
From Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
Tickers DMT MDMA
Tags Cybin (CYBN) Doc Gumshoe MDMA
From Stock Gumshoe
COMPASS Pathways: Positive Psilocybin Trial, High-Dose Group Improves Beyond Depression Reduction
Tickers CMPS
Tags Biotech Market News General
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tickers ATAI CMPS
Tags Topics Benzinga David Bronner
From Benzinga
PA Psilocybin Bill Could Make The State A Frontrunner In Psychedelic Research, Aiding Vets & First Responders
Tags Markets Cannabis U/S/ Centers for Disease Control
From Benzinga
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
Tickers TC
Tags Peter Thiel Nurx partner
From TechCrunch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story